Alethia BioTherapeutics Company
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Industry:
Genomic and Epigenominc Instabillity
Estimated Revenue:
$1M to $10M
Headquarters:
Canada
Founded Date:
2002-01-01